Brief: Ironwood Pharmaceuticals Q3 Revenue USD 91.592 Million Vs. IBES Estimate USD 91.2 Million
07/11/2024 12:00
Nov 07 (Reuters) - Ironwood Pharmaceuticals Q3 EPS USD 0.02. * Q3 adjusted net income USD 3.869 million vs. IBES estimate USD 15.3 million * Q3 basic EPS USD 0.02 * Q3 net income USD 3.646 million * Q3 adjusted EBITDA USD 26.159 million
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation